EYLEA (aflibercept)
OPHTHALMIC - MACULAR DEGENERATION AGENTS·DIABETIC RETINOPATHY·+4
Regeneron Pharmaceuticals, Inc.
Indication
Retinopathy of prematurity
Retinopathy of prematurity is a vasoproliferative eye disorder primarily affecting premature neonates and infants with very low birth weights. Read more about Retinopathy of prematurity
1 drugs 1 manufacturers
Drugs that treat it
Common Retinopathy of prematurity therapies.
Filter & compare in the drug finder →Opens the drug finder with Retinopathy of prematurity preselected.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonRetinopathy of prematurity is a vasoproliferative eye disorder primarily affecting premature neonates and infants with very low birth weights.
It develops when the normal maturation of the retinal vasculature is disrupted after preterm delivery, often compounded by fluctuations in supplemental oxygen exposure.
This interruption triggers an abnormal phase of vessel proliferation and fibrous tissue formation extending into the vitreous.
Severe progression can lead to vitreous hemorrhage, fibrovascular traction, retinal detachment, and potentially permanent visual impairment or blindness.
- nih.gov
Retinopathy of prematurity is a vasoproliferative eye disorder primarily affecting premature neonates and infants with very low birth weights It develops when the normal maturation of the retinal vasculature is disrupted after preterm delivery, often compounded by fluctuations in supplemental oxygen exposure Severe progression can lead to vitreous hemorrhage, fibrovascular traction, retinal detachment, and potentially permanent visual impairment or blindness
- uofmhealth.org
Retinopathy of prematurity is a vasoproliferative eye disorder primarily affecting premature neonates and infants with very low birth weights
- nih.gov
It develops when the normal maturation of the retinal vasculature is disrupted after preterm delivery, often compounded by fluctuations in supplemental oxygen exposure This interruption triggers an abnormal phase of vessel proliferation and fibrous tissue formation extending into the vitreous Severe progression can lead to vitreous hemorrhage, fibrovascular traction, retinal detachment, and potentially permanent visual impairment or blindness
- childrenshospital.org
This interruption triggers an abnormal phase of vessel proliferation and fibrous tissue formation extending into the vitreous
Personalize your experience
Follow Retinopathy of prematurity and get updates as they land.
Create a free account
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.